These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11416677)
1. Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study. Bakris G; Gradman A; Reif M; Wofford M; Munger M; Harris S; Vendetti J; Michelson EL; Wang R; J Clin Hypertens (Greenwich); 2001; 3(1):16-21. PubMed ID: 11416677 [TBL] [Abstract][Full Text] [Related]
2. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II. Vidt DG; White WB; Ridley E; Rahman M; Harris S; Vendetti J; Michelson EL; Wang R; J Hum Hypertens; 2001 Jul; 15(7):475-80. PubMed ID: 11464257 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators. Lacourcière Y; Asmar R Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580 [TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators. Zuschke CA; Keys I; Munger MA; Carr AA; Marinides GN; Flanagan TL; Cushing DJ; Hayes JL; Michelson EL Clin Ther; 1999 Mar; 21(3):464-74. PubMed ID: 10321416 [TBL] [Abstract][Full Text] [Related]
5. The antihypertensive effect and tolerability of candesartan cilexetil, a new generation angiotensin II antagonist, in comparison with losartan. Andersson OK; Neldam S Blood Press; 1998 Jan; 7(1):53-9. PubMed ID: 9551878 [TBL] [Abstract][Full Text] [Related]
6. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. Asmar R; Lacourcière Y J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784 [TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Oparil S; Levine JH; Zuschke CA; Gradman AH; Ripley E; Jones DW; Hardison JD; Cushing DJ; Prasad R; Michelson EL Am J Cardiol; 1999 Aug; 84(3):289-93. PubMed ID: 10496437 [TBL] [Abstract][Full Text] [Related]
8. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension. Melian EB; Jarvis B Drugs; 2002; 62(5):787-816. PubMed ID: 11929332 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan. Azizi M; Chatellier G; Guyene TT; Ménard J J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959 [TBL] [Abstract][Full Text] [Related]
10. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension. Oparil S Am J Cardiol; 1999 Nov; 84(10A):35S-41S. PubMed ID: 10588093 [TBL] [Abstract][Full Text] [Related]
11. Comparison of angiotensin II receptor blockers: impact of missed doses of candesartan cilexetil and losartan in systemic hypertension. Mancia G; Dell'Oro R; Turri C; Grassi G Am J Cardiol; 1999 Nov; 84(10A):28S-34S. PubMed ID: 10588092 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. Kloner RA; Weinberger M; Pool JL; Chrysant SG; Prasad R; Harris SM; Zyczynski TM; Leidy NK; Michelson EL; Am J Cardiol; 2001 Mar; 87(6):727-31. PubMed ID: 11249891 [TBL] [Abstract][Full Text] [Related]
13. Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials. Izzo JL; Weinberg MS; Hainer JW; Kerkering J; Tou CK; J Clin Hypertens (Greenwich); 2004 Sep; 6(9):485-93. PubMed ID: 15365275 [TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring. Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350 [TBL] [Abstract][Full Text] [Related]
15. Candesartan cilexetil: an update of its use in essential hypertension. Easthope SE; Jarvis B Drugs; 2002; 62(8):1253-87. PubMed ID: 12010090 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group. Gradman AH; Lewin A; Bowling BT; Tonkon M; Deedwania PC; Kezer AE; Hardison JD; Cushing DJ; Michelson EL Heart Dis; 1999; 1(2):52-7. PubMed ID: 11720604 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. McInnes GT; O'Kane KP; Istad H; Keinänen-Kiukaanniemi S; Van Mierlo HF J Hum Hypertens; 2000 Apr; 14(4):263-9. PubMed ID: 10805052 [TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Reif M; White WB; Fagan TC; Oparil S; Flanagan TL; Edwards DT; Cushing DJ; Michelson EL Am J Cardiol; 1998 Oct; 82(8):961-5. PubMed ID: 9794352 [TBL] [Abstract][Full Text] [Related]
19. Candesartan cilexetil: an angiotensin II receptor blocker. Stoukides CA; McVoy HJ; Kaul AF Ann Pharmacother; 1999 Dec; 33(12):1287-98. PubMed ID: 10630830 [TBL] [Abstract][Full Text] [Related]
20. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension. Himmelmann A; Keinänen-Kiukaanniemi S; Wester A; Redón J; Asmar R; Hedner T; Blood Press; 2001; 10(1):43-51. PubMed ID: 11332334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]